>
Organization
Eli Lilly & Company
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Eli Lilly & Company

... today that Dr. John Lechleiter, retired President, CEO and Chairman of Eli Lilly and Company, has been elected to the Battelle Board of Directors. This ...
... Eli Lilly VP Robert Brown is making the jump to serve as CEO ...
... Eli Lilly has long been under pressure to replace the revenues it's losing ...
... fruquintinib in colorectal cancer ("CRC") in China, in collaboration with Eli Lilly and Company ("Lilly"), is now imminent. Fruquintinib is also in multiple ongoing clinical ...
... Inc. (NASDAQ:MBRX), Amarin Corporation plc (NASDAQ:AMRN), Clovis Oncology Inc. (NASDAQ:CLVS), Eli Lilly and Company (NYSE:LLY), Novartis AG (NYSE:NVS). Moleculin Biotech, Inc.,(NASDAQ:MBRX)BREAKING NEWS: Moleculin Biotech, a ...
... Eli Lilly in September joined its rivals in the CGRP drug class with ...
... PR Newswire Eli Lilly and Company (NYSE: LLY) has announced the submission of a New Drug Application ...
... such as Sanofi's/Lexicon's Zynquista (sotagliflozin), AstraZeneca's Forxiga (dapagliflozin), Astella's Suglat (ipragliflozin), and Eli Lilly/Boehringer Ingelheim's Jardiance (empagliflozin) are being increasingly investigated in T1D patients and ...
... Eli Lilly has filed for FDA approval of migraine drug lasmiditan. The Big ...
... Advisors LLC, Pfizer Inc., Sofinnova Ventures and Alexandria Venture Investments. Additionally, Eli Lilly and Company invested $15 million in this financing in conjunction with the ...
Subscribe now for full coverage on Eli Lilly & Company
Start My Free Trial